Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 1Phase 4 1Phase 3 1

Status

Completed 47Recruiting 20Unknown 9Active not recruiting 9Not yet recruiting 7Terminated 6Withdrawn 5Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 8NETWORK 1

Study Type

Interventional 9Observational 1

Sponsor

Cancer Type

Breast 3Plasma cell 1Lymphoid 1Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 2Smoking 1Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Melanoma 1Lymphoma, Mantle-Cell 1Genetic Diseases, Inborn 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

pembrolizumab 438Carboplatin 321Nivolumab 293Cyclophosphamide 285Specimen Handling 257Paclitaxel 249Magnetic Resonance Spectroscopy 249Cisplatin 248Radiotherapy 218Dexamethasone 183Gemcitabine 177Biopsy 177durvalumab 169atezolizumab 149Doxorubicin 140Rituximab 138Lenalidomide 135Docetaxel 131Ipilimumab 130Bevacizumab 128Radiation 121Capecitabine 117Etoposide 116Oxaliplatin 114Fluorouracil 110Pemetrexed 109Radiosurgery 108fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

9 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Tablets × Clear all
NCT04503694 2026-05-22

REGINA

Jules Bordet Institute

Phase 2 Active not recruiting
72 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05392608 2026-05-22

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting
130 enrolled
Breast

Breast Neoplasms, Genetic Diseases, Inborn

NCT04802590 2026-05-20

Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

The Lymphoma Academic Research Organisation

Phase 2 Active not recruiting
210 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT04055493 2026-05-11

ADAPTcycle

West German Study Group

Phase 3 Active not recruiting
1,684 enrolled
Breast

Breast Neoplasms

NCT04789057 2026-04-21

Captain

Medical University of Bialystok

Phase 4 Active not recruiting
460 enrolled

Smoking, Pulmonary Disease, Chronic Obstructive

NCT06033092 2025-08-28

TOLERANT

European Institute of Oncology

Phase 2 Active not recruiting
200 enrolled
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT07042711 2025-06-29

Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients

Indonesia University

Phase NA Active not recruiting
300 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT04717700 2025-03-18

SABLe

Odense University Hospital

Phase 2 Active not recruiting
50 enrolled
Plasma cell

Multiple Myeloma

NCT04722575 2025-03-13

NEO-TIM

Fondazione Melanoma Onlus

Phase 2 Active not recruiting
95 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡